Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:704-710
Published online before print July 28, 2003, doi: 10.1161/01.CIR.0000083725.72693.EA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/6/704    most recent
01.CIR.0000083725.72693.EAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsia, H. H.
Right arrow Articles by Marchlinski, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsia, H. H.
Right arrow Articles by Marchlinski, F. E.
Related Collections
Right arrow Hypertrophy
Right arrow Myocardial cardiomyopathy disease

(Circulation. 2003;108:704.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Characterization of Endocardial Electrophysiological Substrate in Patients With Nonischemic Cardiomyopathy and Monomorphic Ventricular Tachycardia

Henry H. Hsia, MD; David J. Callans, MD; Francis E. Marchlinski, MD

From the Electrophysiology Service, Cardiovascular Division, University of Pennsylvania Health System, Philadelphia, Pa.

Correspondence to Henry H. Hsia, MD, Cardiovascular Division, Hospital of University of Pennsylvania, 9 Founders, 3400 Spruce St, Philadelphia, PA 19104. E-mail henry.hsia{at}uphs.upenn.edu

Received March 21, 2002; de novo received December 31, 2002; revision received May 15, 2003; accepted May 16, 2003.

Background— Although catheter mapping has been used to define the endocardial electrogram characteristics in patients with ventricular tachycardia (VT) and coronary disease, characterization of the electrophysiological substrate in patients with VT and nonischemic cardiomyopathy is limited.

Methods and Results— Left ventricular endocardial electroanatomical mapping was performed in 19 patients with nonischemic cardiomyopathy and monomorphic VT with an average of 178±83 sites per chamber mapped. Abnormal bipolar electrogram was defined as endocardial voltage signal amplitude of <1.8 mV. The extent and location of abnormal endocardium was estimated by measuring areas of abnormal electrogram recordings from 3D voltage maps. The origin of VT was approximated by identifying sites of entrainment with concealed fusion or early presystolic activity and/or by pace mapping. Abnormal electrograms were recorded over a 41±28 cm2 area that represented 20±12% of total endocardial surface. The majority of patients (14/19 patients) had only a modest area (<25%) of endocardial abnormality. All patients had abnormal low-voltage endocardial areas located near the ventricular base in the perivalvular region. There were 3±1 VT morphologies per patient. The majority (88%) of the 57 mapped VTs originated from the ventricular base, corresponding to regions with abnormal endocardial electrograms.

Conclusions— Electroanatomical mapping in patients with monomorphic VT and nonischemic cardiomyopathy typically demonstrates a modest-sized basal area of endocardial electrogram abnormalities. The VT site of origin corresponds to these basal electrogram abnormalities. These findings have important implications regarding strategies for VT ablation in this setting.


Key Words: tachycardia • mapping • cardiomyopathy • ablation




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. Corrado, C. Basso, L. Leoni, B. Tokajuk, P. Turrini, B. Bauce, F. Migliore, A. Pavei, G. Tarantini, M. Napodano, et al.
Three-Dimensional Electroanatomical Voltage Mapping and Histologic Evaluation of Myocardial Substrate in Right Ventricular Outflow Tract Tachycardia.
J. Am. Coll. Cardiol., February 19, 2008; 51(7): 731 - 739.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. E. Marchlinski
Perivalvular Fibrosis and Monomorphic Ventricular Tachycardia: Toward a Unifying Hypothesis in Nonischemic Cardiomyopathy
Circulation, October 30, 2007; 116(18): 1998 - 2001.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Dalal, R. Jain, H. Tandri, J. Dong, S. M. Eid, K. Prakasa, C. Tichnell, C. James, T. Abraham, S. D. Russell, et al.
Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
J. Am. Coll. Cardiol., July 31, 2007; 50(5): 432 - 440.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. G. Stevenson and K. Soejima
Catheter Ablation for Ventricular Tachycardia
Circulation, May 29, 2007; 115(21): 2750 - 2760.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. E. Marchlinski and M. Jessup
Timing the Implantation of Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy
J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2483 - 2485.
[Full Text] [PDF]


Home page
CirculationHome page
S. Nazarian, D. A. Bluemke, A. C. Lardo, M. M. Zviman, S. P. Watkins, T. L. Dickfeld, G. R. Meininger, A. Roguin, H. Calkins, G. F. Tomaselli, et al.
Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy
Circulation, November 1, 2005; 112(18): 2821 - 2825.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Corrado, C. Basso, L. Leoni, B. Tokajuk, B. Bauce, G. Frigo, G. Tarantini, M. Napodano, P. Turrini, A. Ramondo, et al.
Three-Dimensional Electroanatomic Voltage Mapping Increases Accuracy of Diagnosing Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
Circulation, June 14, 2005; 111(23): 3042 - 3050.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. S. Desai, J. C. Fang, W. H. Maisel, and K. L. Baughman
Implantable Defibrillators for the Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-analysis of Randomized Controlled Trials
JAMA, December 15, 2004; 292(23): 2874 - 2879.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. E. Marchlinski, E. Zado, S. Dixit, E. Gerstenfeld, D. J. Callans, H. Hsia, D. Lin, H. Nayak, A. Russo, and W. Pulliam
Electroanatomic Substrate and Outcome of Catheter Ablative Therapy for Ventricular Tachycardia in Setting of Right Ventricular Cardiomyopathy
Circulation, October 19, 2004; 110(16): 2293 - 2298.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Soejima, G. Couper, J. M. Cooper, J. L. Sapp, L. M. Epstein, and W. G. Stevenson
Subxiphoid Surgical Approach for Epicardial Catheter-Based Mapping and Ablation in Patients With Prior Cardiac Surgery or Difficult Pericardial Access
Circulation, September 7, 2004; 110(10): 1197 - 1201.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Soejima, W. G. Stevenson, J. L. Sapp, A. P. Selwyn, G. Couper, and L. M. Epstein
Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: The importance of low-voltage scars
J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1834 - 1842.
[Abstract] [Full Text] [PDF]